Literature DB >> 7961851

Structure-function studies on the ubiquinol oxidation site of the cytochrome bo complex from Escherichia coli using p-benzoquinones and substituted phenols.

M Sato-Watanabe1, T Mogi, H Miyoshi, H Iwamura, K Matsushita, O Adachi, Y Anraku.   

Abstract

To characterize the structural features of the quinol oxidation site (the QL site) of the cytochrome bo complex, a heme-copper respiratory oxidase in Escherichia coli, we carried out structure-inhibitory potency analyses using 7 p-benzoquinones and 33 substituted phenols. Their effects on its ubiquinol-1 oxidase activity were compared with those on the cytochrome bd complex in E. coli and on cytochromes o and alpha 1 in Acetobacter aceti. They showed similar structural properties of the QL site, although cytochrome o was more sensitive to 4-cyanophenols, suggesting a specific interaction of the hydrogen bond-accepting cyano group with the binding pocket. Replacing one of the methyl groups of 2,6-dimethyl-p-benzoquinone, which is the most potent competitive inhibitor, with an ethyl group markedly decreased the inhibitory activity, indicating that the QL site specifically recognizes one C = O group with two methyl groups as the ortho-substituents. In substituted phenols, ortho-chlorine substituents were the most effective in recognition, and the electron-withdrawing ability of the para-substituent determined an inhibitory potency, probably by stabilizing an anionic form. Based on these observations, we postulate that the QL site of the cytochrome bo complex asymmetrically recognizes exogenous ligands and that this property accounts for the sequential electron transfer from ubiquinols to the low-spin heme.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961851

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Thermodynamics of electron transfer in Escherichia coli cytochrome bo3.

Authors:  B E Schultz; S I Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

2.  The quinone-binding sites of the cytochrome bo3 ubiquinol oxidase from Escherichia coli.

Authors:  Lai Lai Yap; Myat T Lin; Hanlin Ouyang; Rimma I Samoilova; Sergei A Dikanov; Robert B Gennis
Journal:  Biochim Biophys Acta       Date:  2010-04-20

3.  Behavioral responses of Escherichia coli to changes in redox potential.

Authors:  V A Bespalov; I B Zhulin; B L Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 4.  Electrodes modified with lipid membranes to study quinone oxidoreductases.

Authors:  Sophie A Weiss; Lars J C Jeuken
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

5.  A study of cytochrome bo3 in a tethered bilayer lipid membrane.

Authors:  Sophie A Weiss; Richard J Bushby; Stephen D Evans; Lars J C Jeuken
Journal:  Biochim Biophys Acta       Date:  2010-01-21

6.  Alternative quinone substrates and inhibitors of human electron-transfer flavoprotein-ubiquinone oxidoreductase.

Authors:  Martin Simkovic; Frank E Frerman
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

7.  Identification of the YfgF MASE1 domain as a modulator of bacterial responses to aspartate.

Authors:  Melissa Lacey; Agnieshka Agasing; Rebecca Lowry; Jeffrey Green
Journal:  Open Biol       Date:  2013-06-05       Impact factor: 6.411

8.  Characterization of cytochrome bo3 activity in a native-like surface-tethered membrane.

Authors:  Sophie A Weiss; Richard J Bushby; Stephen D Evans; Peter J F Henderson; Lars J C Jeuken
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

9.  Synthesis and Biological Screening of New Lawson Derivatives as Selective Substrate-Based Inhibitors of Cytochrome bo3 Ubiquinol Oxidase from Escherichia coli.

Authors:  Isam Elamri; Melanie Radloff; Katharina F Hohmann; Vijaykumar D Nimbarte; Hamid R Nasiri; Michael Bolte; Schara Safarian; Hartmut Michel; Harald Schwalbe
Journal:  ChemMedChem       Date:  2020-04-14       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.